A b s t r a c t
Mycobacterium tuberculosis infection is associated with thrombocytosis. We sought to determine if this information might be valuable in evaluating granulomas using acid-fast stains (AFS). Fifty-eight patients with culture-confirmed
Mycobacterium tuberculosis infection is associated with thrombocytosis. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] This effect might be related to increased levels of interleukin 6 12 and may lead to a hypercoagulable state and deep vein thrombosis. 8 The degree of thrombocytosis correlates significantly with the degree of inflammation as measured with the erythrocyte sedimentation rate and serum C-reactive protein. 10 We sought to determine whether this information might be valuable in evaluating granulomas using acid-fast stains (AFS).
Materials and Methods
Patients who had undergone cultures for mycobacteria at Baptist Hospital (Miami, FL) were identified. All positive cultures from 2006 to 2011 were identified, as well as a consecutive series of negative cultures from September 2011 through December 2012. For each patient, the admitting platelet count (either on the day of admission or within 24 hours if not done on admission) was identified, as well as any material that was available for tissue diagnosis. Patients without an admitting platelet count were excluded; only 3 patients were excluded on this basis. Data on C-reactive protein, sedimentation rate, and D-dimer testing were also obtained from the admission medical records. All biopsy and AFS findings were reviewed. "Rare" organisms were defined as 2 or fewer organisms identified per slide.
Statistical analysis was performed with a 2-tailed Mann-Whitney U test for continuous data and a 2-tailed χ 2 test for categorical data. A P value of less than .05 was considered significant.
Upon completion of this activity you will be able to:
• recognize that thrombocytosis is associated with Mycobacterium tuberculosis infection.
• recognize that granulomas in anatomic pathology are more likely to contain acid-fast organisms if the patient has concurrent thrombocytosis.
• recognize the utility of checking the patient's platelet count in evaluating granulomas in anatomic pathology.
The ASCP is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The ASCP designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 Credit ™ per article. Physicians should claim only the credit commensurate with the extent of their participation in the activity. This activity qualifies as an American Board of Pathology Maintenance of Certification Part II Self-Assessment Module.
The authors of this article and the planning committee members and staff have no relevant financial relationships with commercial interests to disclose.
Questions appear on p 690. Exam is located at www.ascp.org/ajcpcme.
Results
Fifty-eight patients with culture-confirmed M tuberculosis infection were compared with 75 patients with atypical mycobacterial infection and 48 patients negative for mycobacteria. Atypical mycobacteria included 33 Mycobacterium avium intracellulare, 9 Mycobacterium abscessus, 1 Mycobacterium asiaticum, 1 Mycobacterium chelonae, 11 Mycobacterium fortuitum, 7 Mycobacterium gordonae, 6 Mycobacterium kansasii, 1 Mycobacterium marinum, and 6 nontuberculosis not otherwise specified (based on genetic testing).
Platelet counts are summarized in ❚Table 1❚. Thrombocytosis (platelet count >360 × 10 3 /μL [360 × 10 9 /L]) was significantly more common in patients with M tuberculosis (50%) than either atypical mycobacterial infection (12%) or negative for mycobacteria (4%; P < .001 for each). Patients with known thrombocytosis and concurrent mycobacterial cultures were significantly more likely to have M tuberculosis (73%) than patients without thrombocytosis (20%; P < .001).
Histologic evaluation of tissue samples of 67 patients showed granulomatous inflammation ❚Table 2❚. Of these, 31 had positive M tuberculosis cultures, 22 had positive atypical mycobacterial cultures, and 14 had negative cultures. AFS results were positive in 37 (55%) patients. Of 19 patients with thrombocytosis, 16 (84%) had a positive AFS result compared with 21 (44%) of 48 without thrombocytosis (P = .003). Of 16 M tuberculosis cases with thrombocytosis, 15 had positive AFS results on histologic evaluation, and the single negative case had a platelet count of 362 × 10 3 /μL (362 × 10 9 /L). However, 3 of these positive stains were initially diagnosed as negative and only recognized as positive on review.
Of the 21 positive AFS results in patients without thrombocytosis, 6 were identified as M tuberculosis, 12 were atypical mycobacterial, and 3 had negative cultures. In 2 of 6 cases of tuberculosis, platelet counts increased significantly within 48 hours of admission to 487 × 10 3 /μL (487 × 10 9 /L) and 510 × 10 3 /μL (510 × 10 9 /L). All 6 M tuberculosis cases had rare organisms. The 12 atypical mycobacterial cases had rare (n = 7) or abundant (n = 5) organisms. All cases with negative cultures and positive AFS had rare organisms.
Of 181 patients in this study, C-reactive protein levels were available in 2, sedimentation rate in 4, and D-dimer studies in 1. Because of these insufficient numbers, no further analysis was performed on these data.
Discussion
One of the more tedious tasks in histology is review of AFS specimens. When faced with a granuloma and an apparently negative AFS result, one is often stuck trying to decide how much longer to examine the AFS specimen and whether one should order additional staining. The advice that one of us (A.A.R.) received in residency from Janina Longtine, MD (who found far more acid-fast organisms than any other attending physician at that institution), was to look long enough to make sure that no one else would find an organism you missed; this is accurate, but not particularly helpful. As a result, any additional information that might help the pathologist decide on which granulomas to spend additional time would be helpful. We believe that the data we present herein are exactly that information.
The information is neither perfect nor complete. Both atypical mycobacterial and M tuberculosis cases do occur in patients without thrombocytosis, and in some cases, the AFS results are positive. Review of AFS results in patients without thrombocytosis remains a difficult task in which the expected outcome is not clear. Review of AFS can be aided by clinical information as well as histologic appearance in these cases. However, the expected outcome for review of AFS specimens in patients with granulomas and thrombocytosis is not unknown; one should expect to find acid-fast organisms in this setting. If the initial review of the AFS specimen in such a setting is negative, the smear should be reviewed again or additional stains obtained. Nevertheless, the platelet count should be viewed as an additional piece of information to be used along with the histologic appearance and additional clinical information. The current study used the admission platelet count to allow uniform collection of data. However, in some cases the platelet count may increase after admission, and this may be a clue that pathologists can use to increase their suspicion of an M tuberculosis infection. The degree of thrombocytosis is also associated with markers of inflammation (erythrocyte sedimentation rate and C-reactive protein). 10 These markers may be valuable in determining how hard to examine an AFS specimen. Nevertheless, we were unable to analyze these variables because, unlike the platelet count, they were unavailable for most patients. At present, it is unclear whether they add value to the platelet count.
The value of platelet counts may depend on the patient population that is evaluated. Not all patients with M tuberculosis infection have thrombocytosis. Indeed, some patients present with low platelets, particularly in Third World settings. 7 We hypothesize that thrombocytosis may be most useful in making a diagnosis in the industrialized world, where the stage of disease may not be as advanced and the underlying health of the patient may not be as poor as in other settings. Nevertheless, evaluation of these findings in other settings may be valuable.
We conclude that patients whose specimens were sent for mycobacterial culture and thrombocytosis evaluation had an increased risk for M tuberculosis. Patients with granulomas and thrombocytosis are more likely to have positive AFS results, which usually show M tuberculosis. Finally, patients with initially negative AFS results and thrombocytosis deserve to receive additional evaluation of the AFS.
